[1]
H. Özer, Y. Öztürk, F. Yönet, İsmail Baloğlu, and K. Türkmen, “Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer: Amyloidosis and Canakinumab”, J Eur Int Med Prof, vol. 1, no. 3, Jul. 2023.